Vital Infrastructure (VITL.UN) Canadian healthcare REIT investment analysis featuring the company logo, medical facilities, distributions, financial performance and investment risks.

Vital Infrastructure (TSX: VITL.UN): Healthcare Real Estate, Monthly Income, and the Price of a Turnaround

Same Trust, New Name

Vital Infrastructure Property Trust trades on the Toronto Stock Exchange as VITL.UN. If the name is unfamiliar, the older one may not be: until March 2026 it was Northwest Healthcare Properties Real Estate Investment Trust, ticker NWH.UN. The name change was announced on February 24, 2026 with the 2025 results and completed on March 11, 2026, when the ticker also changed. It is the same Ontario trust with the same unitholders, the same assets and the same history. Nothing about the rename created a new vehicle or reset the record. “Infrastructure” is the trust’s way of describing hospitals and clinics as essential assets, not a change of business. A healthcare landlord is not a utility, however: it has no regulated rate base or guaranteed return, and its income depends on its leases and on its tenants’ ability to pay.

The business is simple to state. Vital owns buildings in which health care is delivered and collects rent from the hospital operators, clinic groups and other organizations that occupy them. At September 30, 2026, according to its third quarter 2026 MD&A, it held interests in 107 properties totalling 11.4 million square feet, 96.9 per cent occupied, with a weighted average remaining lease term of 12.7 years and about $5.8 billion of assets under management. The units closed at $4.53 on November 18, 2026, which values the trust at roughly $1.1 billion. It pays $0.03 per unit each month, or $0.36 a year, a yield of about 7.9 per cent at that price. All figures in this article are in Canadian dollars unless noted.

That yield, and a price well under the trust’s reported net asset value, are the reasons investors look at it. They are also the reasons to be careful, because this is a REIT that cut its distribution by more than half in 2023, sold large parts of its portfolio to repair its balance sheet and is now a much smaller business than the one it was. The question this article tries to answer is whether the turnaround has produced something worth owning for a decade or more, and at what price.

What Healthcare Real Estate Means in Practice

Vital is a landlord, not a hospital operator. A typical lease is long, often triple net, which means the tenant pays property taxes, insurance and most operating costs, and it usually carries scheduled or inflation-linked rent increases. The tenant is a hospital group, a physician practice, a rehabilitation provider or a health system. Vital’s job is to own the building, keep it fit for purpose and collect rent.

The portfolio has concrete examples. In Brazil, its largest tenant is Rede D’Or, a hospital operator that the MD&A says is rated AAA(bra) by S&P Global Ratings and Fitch. That is a Brazilian national-scale rating, not a global one, and it describes the tenant, not the lease. Rede D’Or accounted for 21.3 per cent of revenue at September 30, 2026. In Ottawa, Vital bought a transitional-care facility in March 2026 for $51.3 million, leased on a triple-net basis to The Ottawa Hospital for about 15 years with contractual rent increases. In Brooklyn, it bought the East New York Health Hub in July 2026 for $126.7 million (US$89.9 million), a 142,000-square-foot outpatient building leased to AdvantageCare Physicians with about 11 years of lease remaining. In Australia, it holds a 30 per cent interest in a joint venture that owns private hospitals, including 12 hospitals leased to Healthscope, an operator now in receivership that the MD&A says has paid its rent to date. Calvary Health Care is expected to become the tenant under a new lease, but at the Q3 reporting date that transition was still targeted for completion by November 30, 2026 and subject to documentation and regulatory approvals.

The advantages are real. Hospitals and surgical centres are expensive to build and hard to relocate, so tenants stay and leases run long, and an ageing population needs more care. In a March 2026 investor presentation, based on what it calls management’s internal analysis, Vital classifies about 47 per cent of tenant funding as AA-plus government and self-pay sources and 49 per cent as A rated private insurance. Those are ratings of the funding sources behind tenants, not of the tenants themselves, and a strongly rated payer does not guarantee an individual operator’s lease obligations.

Each advantage has a matching risk. Demand for care does not guarantee that a particular operator can pay its rent, and Healthscope showed that a large operator can fail while its buildings remain essential. A hospital designed for one use is hard to repurpose, and revenue earned in reais, Australian dollars or euros is exposed to currency movements. Tenant concentration is rising: the ten largest tenants made up 45.2 per cent of revenue at September 30, up from 36.8 per cent at December 2025 as European and New Zealand assets left the base.

Where the Properties Are

The footprint has shifted a great deal in two years. Europe, once a major region, is being exited. New Zealand is now held mostly through a minority stake in another listed trust, discussed below. What remains is concentrated in four regions, shown here with the trust’s own figures for September 30, 2026.

RegionPropertiesOccupancyAverage lease termShare of NOICap rate
North America (Canada 48, U.S. 12)6091.2%5.7 years43%6.70%
Brazil8100%16.2 years29%8.91%
Australia25100%14.2 years20%5.72%
Europe1499.6%18.1 years8%6.43%

Source: Vital Infrastructure third quarter 2026 MD&A and supplemental disclosures. NOI is net operating income, rent less property costs. The cap rate is the valuation yield the trust applies to each region.

The table shows why the portfolio is two different businesses. North America is the home market and the growth focus, but it has the lowest occupancy and shortest leases. Brazil, Australia and Europe have near-full occupancy and leases of 14 to 18 years, but they are where the currency and single-tenant risks sit. Same-property NOI, which measures rent growth on buildings owned in both periods, rose 2.6 per cent in the third quarter of 2026 compared with a year earlier.

Acquisitions are what the trust says will rebuild earnings. It spent about $169 million on North American acquisitions in the third quarter, at a blended cap rate of about 7 per cent and a lease term of about eight years, after agreeing to sell 33 European properties to TPG Real Estate for EUR 400 million. This article uses the trust’s proportionate figures, which count only its share of jointly held assets and debt, unless it says otherwise.

Two Vitals: Vital Infrastructure and Vital Healthcare

The name causes confusion. Vital Healthcare Property Trust (NZX: VHP) is a separate trust listed in New Zealand that owns hospitals and medical property in Australia and New Zealand. Northwest used to manage it under an external contract and owned a large minority of its units. On December 30, 2025, Vital Healthcare terminated that management contract and paid Northwest NZ$214 million (about C$170 million) for it. After that the trust stopped consolidating Vital Healthcare in its statements, which is one reason the 2025 and 2026 figures are hard to compare.

On November 17, 2026, Vital Infrastructure announced the sale of half its holding in a block trade of about 95.9 million units, for net proceeds of about $123.7 million (NZ$157.4 million). It will keep about 11.9 per cent of Vital Healthcare, subject to a six-month escrow unless the underwriters agree to an earlier date, and expects settlement on or about November 23. The REIT said it will use the money to repay credit facilities and to fund acquisition opportunities in North America; it did not say how much goes to each, and the announcement discloses no tax or accounting effect. New Zealand reports put the price at NZ$1.65 a unit, and Vital Healthcare’s units fell 5.6 per cent to NZ$1.69 in New Zealand trading on November 18. At September 30 the trust’s financial statements carried the stake at $322.0 million but showed a market value of $285.7 million, and they noted no impairment test had been performed, with a reassessment planned for December 31, 2026.

The sale matters for two reasons. It gives a real market price for assets that Vital Infrastructure had valued more highly, and once settled it halves a stream of distributions that totalled $11.4 million in the first nine months of 2026.

The Monthly Distribution

Vital Infrastructure declared its November 2026 distribution on November 13: $0.03 per unit, payable on December 15 to unitholders of record on November 30, which is $0.36 a year. The same amount has been declared every month this year.

The history is what makes the number matter. Before September 2023 the trust paid $0.80 a unit a year. In September 2023 it cut that to $0.36, a reduction of 55 per cent, as part of a strategic review. An RBC analyst quoted by the Globe and Mail estimated that the old distribution was about 130 per cent of cash flow, which is to say it could not be funded. The distribution has already been reset once because the business could not carry it, so today’s $0.36 should be tested against cash flow every quarter, not assumed.

A tax point applies to any Canadian REIT. Distributions from a trust are not ordinary eligible dividends. They can be a mix of other income, capital gains and return of capital, and the mix changes from year to year. Return of capital is not taxed when received but lowers the adjusted cost base of the units, which raises the eventual capital gain. The composition is reported by the issuer after year-end, and investors should use that reporting rather than assume a fixed split. Our guide to REITs versus direct real estate explains how the components are taxed in registered and non-registered accounts.

How Well Is the Distribution Covered?

Four numbers are easy to confuse. Reported adjusted funds from operations, or AFFO, is the trust’s own measure of recurring cash flow. Normalized AFFO is my adjustment of it for items that recur or are about to change. Operating cash flow is the number on the cash flow statement. Distributions paid is what unitholders received.

Reported AFFO was $77.5 million for the nine months to September 30, 2026, or $0.31 a unit, against distributions paid of $67.5 million, a payout ratio of 87 per cent. Operating cash flow on the cash flow statement was only $50.8 million over the same period, and $5.8 million in the third quarter against $22.5 million of distributions. Most of that gap is classification rather than a missing $27 million. Since Vital Healthcare was deconsolidated, distributions received from it and from other equity-accounted investments are recorded under investing activities, while AFFO counts them as income. The MD&A adds $21.7 million of this distribution income back to operating cash flow, which turns the nine-month position into a $5.0 million surplus over distributions paid and leaves the third quarter $9.5 million short. The add-back excludes distributions tied to the sale of the European joint venture.

Even after the add-back, operating cash flow of $72.5 million is $5.0 million below AFFO over nine months, and the third-quarter gap is wider because $8.6 million of working capital went out. Interest and income taxes paid are already deducted within operating cash flow. The issuer does not reconcile AFFO to operating cash flow, and I cannot allocate the remaining difference to particular items from the filings; it may reflect timing or other classification. Nothing I read shows that AFFO overstates distributable cash flow, and nothing proves that it does not, so the cash flow figures warrant continued scrutiny.

MeasureBasisAmountAgainst $0.36 distribution
Reported AFFONine months, actual$77.5M ($0.31 a unit)87% payout
Operating cash flowNine months, actual$50.8M ($72.5M with MD&A add-back)Below $67.5M paid as reported; above it with the add-back
Reported AFFOThird quarter x 4$101.6M ($0.406 a unit)89% payout
Normalized AFFOAnnualized$95.9M ($0.383 a unit)94% payout
Conservative AFFOAnnualized$81.9M ($0.328 a unit)110% payout

Source: Vital Infrastructure Q3 2026 financial statements and MD&A; normalized and conservative figures are Sovereign Canadian calculations.

My normalized figure starts with the third quarter’s annualized AFFO and corrects for what will not repeat. It raises capital spending to last year’s level of about $14.1 million, because the third quarter deducted only $2.4 million. It deducts about $0.01 a unit, the issuer’s own estimate of the cost of lease incentives in the first 48 months of the proposed Calvary lease. That transaction remains subject to completion, so the deduction is a contingent assumption. It adds roughly $2 million of interest savings from the new October debenture, and subtracts the net effect of selling half the Vital Healthcare stake. The conservative figure also treats unit-based compensation as a real cost, since most of it is settled in units rather than cash, and allows for an 8 per cent fall in the Brazilian real. Those are judgments, not company forecasts.

On the normalized figure, coverage is about 94 per cent, which leaves limited room for adverse developments. Distributions are covered by reported and normalized AFFO. Operating cash flow, with the MD&A’s add-back, roughly matches distributions and leaves little cushion. If net operating income fell 5 per cent with no offsetting savings, normalized AFFO would drop to about $0.34 a unit and the payout would pass 100 per cent, and a 10 per cent fall would take it to about 122 per cent.

Interest rates matter, but how much depends on what reprices. A 100 basis point rise on floating-rate debt alone would lower normalized AFFO to about $0.36 or $0.37 a unit, a payout of 98 to 99 per cent. The same rise on all debt that reprices by the end of 2028, including fixed-rate maturities that must be refinanced, would take it to about $0.34 and above 105 per cent. The two cases bracket the risk, and the second assumes every maturity reprices 100 basis points higher. The issuer says only that the majority of its debt is fixed or economically fixed, and it has not said how the Vital Healthcare proceeds will be split between debt repayment and acquisitions. My floating-rate estimates, $398 million if the proceeds repay debt and $522 million if they are redeployed, are editorial estimates, and the ranges above cover both. These stress tests do not incorporate potential management responses, contractual rent escalators or other changes in operating conditions. They illustrate the sensitivity of distribution coverage to borrowing costs rather than predict a specific outcome.

What Went Wrong at Northwest

The earlier strategy was growth by acquisition across many countries, funded with debt and equity. At its peak in 2022 Northwest had 233 properties and about $10.9 billion of assets under management. Net asset value per unit was $13.80 at the end of 2022 and is $7.43 today.

Then interest rates rose. The trust refinanced debentures at 10 per cent in 2023, and a Brazilian loan carried an 11.58 per cent variable rate. A distribution of $0.80 sat on top of a business that could not fund it. The distribution reinvestment plan was suspended in June 2023, a strategic review began in August, the founder gave up his roles as chief executive and chair, and the distribution was cut in September.

The repair came in steps. In 2024 it sold its United Kingdom portfolio to Assura for about C$885 million at a 5.9 per cent cap rate and said the net proceeds would repay $690 million of debt costing 7.9 per cent. In 2025 it sold its remaining Assura shares and further non-core assets, issued $500 million of unsecured debentures, and repaid debt with the proceeds. A new chief executive, Zach Vaughan, took over in July 2025. The Vital Healthcare management contract was bought out in December, the European sale was agreed in February 2026 and closed in two parts, the Netherlands in April and Germany in June, and the sale of half the Vital Healthcare stake was announced in November 2026.

A Healthier Balance Sheet, Not Yet a Healthier Business

Three questions are often treated as one: is the balance sheet healthier, is the underlying business healthier, and are results per unit improving? On the first, the answer is clearly yes. Proportionate debt to gross book value fell from 58.3 per cent at the end of 2024 to 52.4 per cent a year later and 49.9 per cent at September 30, 2026, and proportionate debt fell from $2.686 billion to $1.891 billion. In October the trust issued $300 million of 4.865 per cent debentures due in 2029 and redeemed all $152.1 million of its 6.25 per cent convertible debentures due 2027. It reports liquidity of $357.4 million.

Better does not mean comfortable. Debt is about 8.5 times adjusted EBITDA, interest coverage is 2.2 times and the largest refinancing concentration is $602.7 million of proportionate debt due in 2028. For perspective, the 2025 incentive plan in the 2026 management information circular rewarded a proportionate leverage target of 54.6 per cent.

On the second question, the business is simpler, cheaper to run and less exposed to Europe. But concentration has risen, North American occupancy is 91.2 per cent, and the trust now depends on acquisitions to restore growth.

On the third, the evidence is weaker. On a diluted basis, AFFO per unit was $0.85 in 2021 (the trust also reported $0.87 on a basic basis), $0.42 in 2025 and $0.10 in the third quarter of 2026, which is about $0.40 annualized, or $0.38 on my normalized basis. Net asset value per unit fell from $14.47 in 2021 to $7.43. That comparison is not like for like. The 2021 trust had 197 properties against 107 today, consolidated Vital Healthcare, earned management fees from the platforms it ran and reported AFFO under earlier conventions, while today’s figure counts only cash distributions from the Vital Healthcare holding, and my normalization is not the trust’s own. Reported AFFO per unit is substantially lower than it was in 2021, but changes in the portfolio, consolidation and reporting conventions prevent a precise like-for-like comparison of underlying earning power. A smaller company with less debt can be healthier and still earn much less per unit, and so far Vital has done both. Sustainable growth in cash flow per unit has not yet been demonstrated.

What Is Inside the $7.43 Net Asset Value

Vital reports net asset value of $7.43 a unit at September 30, 2026, so $4.53 is a discount of about 39 per cent. A discount to net asset value is not by itself a margin of safety, because the value can be wrong, and in this case about $1.26 of the $7.43 comes from adjustments to book equity.

Item$ millions
Unitholders’ equity (IFRS book)1,541.6
Add: deferred tax liability223.3
Add: Manager valuation adjustment113.0
Add: unit-based compensation liabilities18.3
Less: derivatives, net(1.1)
Less: Vital Healthcare marked to market(36.4)
Net asset value1,858.8
Per unit (250.0 million units)$7.43

Source: Vital Infrastructure Q3 2026 MD&A, page 43. IFRS book equity is $6.17 a unit.

These adjustments are not all invalid. The deferred tax add-back reflects the view that the tax recorded on property gains will not all be paid while the assets are held, a common practice, though the trust recorded about $31 million of current tax in the third quarter connected to the 2025 Vital Healthcare transaction, which shows some tax does become payable. The Manager valuation adjustment of $113.0 million is the trust’s estimate of the value of its European and Australian asset management operations, according to the MD&A footnote. The MD&A does not explain how that is valued, and the European staff moved to TPG in June. The Vital Healthcare line already reflects the issuer’s market-value adjustment: it is the gap between the $322.0 million carrying value and the $285.7 million quoted market value of the whole holding at September 30. Reported NAV therefore values the stake at market, although the financial statements carry it higher and no impairment test has been performed. The revised Calvary lease terms also reduced reported NAV by about $26.6 million.

Property values are the larger question. Independent appraisers valued about $218.8 million of properties during the first nine months of 2026, which the MD&A calls about 7 per cent of fair value, compared with 26 per cent, or $1.1 billion, a year earlier. The MD&A ties that to a multi-year appraisal cycle in which each property is valued externally at least once, so a low share in a given nine months is not proof of weak valuations. It does mean that most reported values rest on the trust’s own models, and actual sales are the check. The sales of 2024 and 2025 at 5.9 and 6.2 per cent cap rates support the reported values, while the Vital Healthcare stake carried above its market price argues the other way.

Sensitivity is large. By my calculation, raising every region’s cap rate by 25 basis points reduces the value of proportionate investment properties by about $119 million, or $0.48 a unit, 50 basis points by about $230 million ($0.92), and 100 basis points by about $431 million ($1.72, or 23 per cent of net asset value). Proportionate debt to gross book value would rise from 49.9 per cent to roughly 51.5, 53.1 and 56.3 per cent. My adjusted net asset value makes further judgments, none of them accounting corrections and none of them implying that the issuer’s add-backs are invalid: it haircuts half of the Manager adjustment and half of the deferred tax add-back, deducts about $0.14 for the fall in Vital Healthcare units between September 30 and the November 17 block trade (not a second deduction of the September 30 mark-down, which reported NAV already contains), and allows for an 8 per cent decline in the Brazilian real. The result is about $6.41 a unit, so the units trade at about 0.71 times it. A peer-like multiple of 0.70 to 0.90 times adjusted net asset value gives roughly $4.49 to $5.77, which brackets the current price.

Owning It for 10 to 20 Years

For a holding period measured in decades, three things matter more than the next distribution cheque. The first is whether the buildings keep being needed and paid for. On that, long leases, specialized buildings and ageing populations are real strengths, and the tenant funding mix is good. The second is whether the tenants stay solvent, where Healthscope, Brazil’s single dominant tenant and rising concentration are the open risks. The third is whether cash flow per unit can grow while leverage stays prudent.

That last point is the hardest. A REIT can grow its total assets by borrowing and issuing units while its cash flow per unit stays flat or falls, and Northwest’s history is an example. Compounding comes from per-unit cash flow. Vital’s lease structures help: Brazilian and many other leases carry indexation, same-property NOI grew 2.6 per cent in the third quarter, and acquisitions at 7 per cent cap rates against debt costing about 5 per cent add some. Against that, each new building needs capital spending, the proposed Calvary lease would reduce AFFO by about a cent a unit, currency swings can reverse gains, and the cost of equity is too high, with units at a 39 per cent discount to reported value, to fund growth by issuing units.

At 94 per cent normalized coverage there is no excess to distribute, so a raise would take AFFO growth of a few per cent a year and time.

Governance deserves a neutral reading. The 2026 circular describes seven of eight trustees as independent and the chair as independent, while also reporting that Kolter Capital, associated with the chair, holds about 10.9 per cent of the units. Significant ownership can align interests, but it does not by itself indicate strong governance. The circular states that no informed person has a material interest in any transaction since January 1, 2025, and I found no related-party fees in the parts I read, which covered most but not all of the document. The short-term incentive plan weights AFFO per unit at 25 per cent and leverage at 15 per cent, with no weight on net asset value, which aligns pay with per-unit cash flow.

What the Price Has to Be

My test is whether the units can earn at least 9.5 per cent a year in Canadian dollars over ten years. That is Sovereign Canadian’s illustrative hurdle, not a rule for every investor, and the approach is simple: estimate cash flows per unit under three scenarios, weight them, and find the single rate of return on the weighted cash flows. The scenario assumptions, probabilities and exit multiples below are editorial judgments, not company forecasts.

Five-year scenarioBearBaseBull
Judgmental probability30%50%20%
AFFO per unit, starting$0.328$0.383$0.393
AFFO growth a year-1%+2%+5%
AFFO per unit, year five$0.312$0.423$0.502
Distribution, year five$0.28$0.38$0.45
Cumulative distributions$1.48$1.84$2.05
Exit multiple of AFFO9.0x11.5x13.5x
Terminal unit price$2.80$4.87$6.78
Annualized return from $4.53-1.3%9.3%16.1%

The bear case includes a second distribution cut, to $0.28 in year two. The model holds the distribution at $0.36 and raises it by up to 5 per cent a year only while it stays at or below 90 per cent of AFFO; the 5 per cent step and the 90 per cent ceiling are my modelling assumptions, not announced policy. The base case’s exit multiple of 11.5 times is slightly below the 11.8 times the units trade on today, so it assumes no revaluation and no closing of the discount. Weighting the yearly cash flows 30, 50 and 20 per cent and calculating one return on the result gives an expected return of about 8.2 per cent a year over five years and about 8.5 per cent over ten, which is below 9.5 per cent. The base case alone is 9.3 per cent over ten years, narrowly short, and the result is sensitive: with base AFFO growth of 3 per cent and a 12 times exit multiple, the base return rises to about 11 per cent, and with growth of 1 per cent and 10 times it falls below 8 per cent. The conclusion changes only if the bull probability rises to about 30 per cent while the bear falls to 20.

Three methods bracket value. Normalized AFFO at a multiple of 11.5, a modest discount to healthier peers for leverage, currency and history, gives about $4.41. Adjusted net asset value at 0.80 times gives about $5.13. The price that returns exactly 9.5 per cent a year over ten years on the weighted scenarios is $4.25. Their average is about $4.60, within a range of roughly $4.25 to $5.15, and I would not read more precision into it than that. A unit can trade slightly below a blended fair value and still miss a required return, because fair value averages several methods while the hurdle price asks what entry price delivers 9.5 per cent on the scenarios. On that basis, $4.53 is roughly a fair price for the risk, but not a bargain relative to the hurdle.

The entry prices follow from the hurdle, and they are outputs of a subjective scenario model, not objective boundaries. Above about $4.25 the expected return falls short of 9.5 per cent, so at $4.53 I would not start a new position. An attractive accumulation price, 10 per cent below that, is about $3.82, where the expected ten-year return is about 11 per cent, and a strong-buy price, 20 per cent below, is about $3.40, where it is about 13 per cent. At $4.79, the price on November 10, the expected return was about 7.7 per cent, and at $5.00 about 7.1 per cent. These conclusions are dated November 18, 2026 and change with the price.

The conclusion follows the evidence. Avoiding a new purchase at $4.53 is not the same as telling existing unitholders to sell. An expected return of about 8.5 per cent with a covered, if thin, monthly distribution can be reasonable for someone who already owns the units and has to weigh taxes and alternatives. What would improve the case: normalized AFFO above about $0.42 for several quarters, the 2028 maturities refinanced at current costs, leverage below 8 times EBITDA and a successful Calvary transition. What would weaken it: coverage above 100 per cent on a normalized basis, a refinancing well above current rates, further sales below reported values, or a stress at Rede D’Or or in the Brazilian economy. For more background on how REITs fit in a portfolio, see our guide to REITs versus direct real estate, and for the currency backdrop, our note on Brazil after the October election.

This article is general information, not personal financial advice, and every price and figure is dated as stated.

Leave a Reply

Your email address will not be published. Required fields are marked *